IMAB362
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
16 Background: Physiologically, the tight junction protein CLDN18.2 is present only in the gastric mucosa. Upon malignant…
BackgroundIn recent years, a better understanding of tumor biology and molecular features of gastric cancer has been reached. It…
ABSTRACT In healthy tissue, the tight junction protein Claudin 18.2 (CLDN18.2) is present only in the gastric mucosa. Upon…
LBA4001Background: Claudin18.2 (CLDN18.2) is a tight junction protein expressed by several cancers including gastric and GEJ…
In recent years, various new agents have been investigated for the treatment of advanced gastric cancer (AGC). The anti-HER2…
e15079 Background: IMAB362 is the first-in-class monoclonal antibody against the tight junction molecule claudin 18.2 (CLDN18.2…
The majority of pancreatic neoplasms are characterized by a generally lethal progress within a short period of time after primary…
ABSTRACT Aim: IMAB362 is a monoclonal antibody specifically targeting claudin 18 isoform 2 (CLDN18.2), which is expressed on…
4080 Background: IMAB362 is a monoclonal antibody targeting isoform 2 of the tight junction component claudin 18 (CLDN18.2), a…